BEIJING – Following on the heels of a flurry of policies to stimulate tiered medical visits and treatment in China, drug makers in the country including Sanofi now see new openings to enter urban markets, this time with a focus on community health service centers.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?